UTMB Health and UTHealth Houston are leading a groundbreaking $50 million statewide clinical trial to explore ibogaine as a potential treatment for addiction, PTSD, and traumatic brain injury — a first-of-its-kind effort that could put Texas at the forefront of behavioral health innovation.